Mark A. Tepper

2.6k total citations · 1 hit paper
36 papers, 2.1k citations indexed

About

Mark A. Tepper is a scholar working on Molecular Biology, Immunology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Mark A. Tepper has authored 36 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Immunology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Mark A. Tepper's work include Toxin Mechanisms and Immunotoxins (7 papers), Natural product bioactivities and synthesis (6 papers) and Immune Response and Inflammation (5 papers). Mark A. Tepper is often cited by papers focused on Toxin Mechanisms and Immunotoxins (7 papers), Natural product bioactivities and synthesis (6 papers) and Immune Response and Inflammation (5 papers). Mark A. Tepper collaborates with scholars based in United States, United Kingdom and Germany. Mark A. Tepper's co-authors include Steven G. Nadler, Jeffrey A. Ledbetter, Peter S. Linsley, Marylou G. Gibson, Jennifer Johnson, Philip M. Wallace, Bernice Schacter, Charles E. Mazzucco, Richard G. MacDonald and James L. Roberts and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Mark A. Tepper

36 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunosuppression in Vivo by a Soluble Form of the CTLA-4 T Cell Activation Molecule

1992 692 citations Peter S. Linsley, Jeffrey A. Ledbetter et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark A. Tepper United States	19	942	859	284	236	235	36	2.1k
Shiro Nozawa Japan	31	672 0.7×	1.5k 1.8×	244 0.9×	315 1.3×	774 3.3×	151	3.5k
Véronique Baron France	33	1.1k 1.1×	2.0k 2.4×	263 0.9×	224 0.9×	772 3.3×	57	3.7k
Jayne Chin United States	20	845 0.9×	1.1k 1.3×	69 0.2×	236 1.0×	478 2.0×	22	2.1k
S. Frieda A. Pearce United States	10	1.4k 1.5×	1.6k 1.9×	91 0.3×	266 1.1×	383 1.6×	12	3.2k
Michael A. Davitz United States	16	563 0.6×	986 1.1×	101 0.4×	166 0.7×	211 0.9×	21	2.2k
Manabu Nakashima Japan	30	1.1k 1.2×	769 0.9×	201 0.7×	198 0.8×	384 1.6×	91	2.4k
Masaru Taniguchi Japan	24	1.0k 1.1×	650 0.8×	76 0.3×	148 0.6×	196 0.8×	65	2.0k
Olivier Donzé Switzerland	25	979 1.0×	2.3k 2.6×	101 0.4×	253 1.1×	308 1.3×	35	3.5k
Abby Maizel United States	30	1.1k 1.1×	919 1.1×	79 0.3×	106 0.4×	450 1.9×	77	2.2k
Akiko Furuya Japan	26	460 0.5×	1.9k 2.2×	116 0.4×	333 1.4×	424 1.8×	65	3.0k

Countries citing papers authored by Mark A. Tepper

Since Specialization

Citations

This map shows the geographic impact of Mark A. Tepper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Tepper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Tepper more than expected).

Fields of papers citing papers by Mark A. Tepper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Tepper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Tepper. The network helps show where Mark A. Tepper may publish in the future.

Co-authorship network of co-authors of Mark A. Tepper

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Tepper. A scholar is included among the top collaborators of Mark A. Tepper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Tepper. Mark A. Tepper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tarique, Abdullah A., Tama Evron, George Zhang, et al.. (2020). Anti-inflammatory effects of lenabasum, a cannabinoid receptor type 2 agonist, on macrophages from cystic fibrosis. Journal of Cystic Fibrosis. 19(5). 823–829. 15 indexed citations

Gilroy, Derek W., Roel P. H. De Maeyer, Mark A. Tepper, et al.. (2020). Treating exuberant, non-resolving inflammation in the lung; Implications for acute respiratory distress syndrome and COVID-19. Pharmacology & Therapeutics. 221. 107745–107745. 8 indexed citations

Tepper, Mark A., Robert B. Zurier, & Sumner Burstein. (2014). Ultrapure ajulemic acid has improved CB2 selectivity with reduced CB1 activity. Bioorganic & Medicinal Chemistry. 22(13). 3245–3251. 48 indexed citations

McKenna, Sean D., et al.. (2004). Formation of Human IFN- β Complex with the Soluble Type I Interferon Receptor IFNAR-2 Leads to Enhanced IFN Stability, Pharmacokinetics, and Antitumor Activity in Xenografted SCID Mice. Journal of Interferon & Cytokine Research. 24(2). 119–129. 30 indexed citations

Tepper, Mark A., et al.. (2003). Military Infrared Technology Advances Diabetes Research. Diabetes Technology & Therapeutics. 5(2). 283–288. 3 indexed citations

Novick, Daniela, Roustem Nabioullin, Sean D. McKenna, et al.. (2000). The Neutralization of Type I IFN Biologic Actions by Anti-IFNAR-2 Monoclonal Antibodies Is Not Entirely Due to Inhibition of Jak-Stat Tyrosine Phosphorylation. Journal of Interferon & Cytokine Research. 20(11). 971–982. 18 indexed citations

Chalupny, N. Jan, A Aruffo, James M. Esselstyn, et al.. (1995). Specific binding of Fyn and phosphatidylinositol 3‐kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains. European Journal of Immunology. 25(10). 2978–2984. 46 indexed citations

Nadler, Steven G., et al.. (1995). Elucidating the Mechanism of Action of the Immunosuppressant 15-Deoxyspergualin. Therapeutic Drug Monitoring. 17(6). 700–703. 37 indexed citations

Dhingra, Kapil, Daniel J. Booser, Aman U. Buzdar, et al.. (1994). Suppression of Human Anti-Mouse Antibody Response to Murine Monoclonal Antibody L6 by Deoxyspergualin: A Phase I Study. Advances in experimental medicine and biology. 353. 193–202. 5 indexed citations

10.

Alegre, Maria‐Luisa, Husain Sattar, Kevan C. Herold, et al.. (1994). PREVENTION OF THE HUMORAL RESPONSE INDUCED BY AN ANTI-CD3 MONOCLONAL ANTIBODY BY DEOXYSPERGUALIN IN A MURINE MODEL1. Transplantation. 57(12). 1786–1794. 8 indexed citations

11.

Nadeau, Kari C., Steven G. Nadler, Mark G. Saulnier, Christopher T. Walsh, & Mark A. Tepper. (1994). Quantitation of the Interaction of the Immunosuppressant Deoxyspergualin and Analogs with Hsc70 and Hsp90. Biochemistry. 33(9). 2561–2567. 98 indexed citations

12.

Tepper, Mark A., et al.. (1994). Tolerance induction by soluble CTLA4 in a mouse skin transplant model.. PubMed. 26(6). 3151–4. 13 indexed citations

13.

Siegall, Clay B., Denny Liggitt, Dana F. Chace, Mark A. Tepper, & H. Perry Fell. (1994). Prevention of immunotoxin-mediated vascular leak syndrome in rats with retention of antitumor activity.. Proceedings of the National Academy of Sciences. 91(20). 9514–9518. 47 indexed citations

14.

Thomas, Francis T., Mark A. Tepper, Judith M. Thomas, & Carl E. Haisch. (1993). 15‐Deoxyspergualin: A Novel Immunosuppressive Drug with Clinical Potentiala. Annals of the New York Academy of Sciences. 685(1). 175–192. 24 indexed citations

15.

Nadler, Steven G., Jeffrey S. Cleaveland, Mark A. Tepper, Christopher T. Walsh, & Kari C. Nadeau. (1993). Studies on the Interaction of the Immunosuppressant 15‐Deoxyspergualin with Heat Shock Proteins. Annals of the New York Academy of Sciences. 696(1). 412–414. 3 indexed citations

16.

Tepper, Mark A., et al.. (1993). 15‐Deoxyspergualin, a Novel Immunosuppressive Drug: Studies of the Mechanism of Action. Annals of the New York Academy of Sciences. 685(1). 136–147. 19 indexed citations

17.

Tepper, Mark A., et al.. (1993). Effects of 15‐Deoxyspergualin on the Expression of Surface Immunoglobulin in 70Z/3.12 Murine Pre‐B Cell Line. Annals of the New York Academy of Sciences. 685(1). 205–206. 3 indexed citations

18.

Pai, Lee H., David J. FitzGerald, Mark A. Tepper, et al.. (1990). Inhibition of antibody response to Pseudomonas exotoxin and an immunotoxin containing Pseudomonas exotoxin by 15-deoxyspergualin in mice.. PubMed. 50(24). 7750–3. 56 indexed citations

19.

MacDonald, Richard G., Suzanne R. Pfeffer, Lisa M. Coussens, et al.. (1988). A Single Receptor Binds Both Insulin-Like Growth Factor II and Mannose-6-Phosphate. Science. 239(4844). 1134–1137. 306 indexed citations

20.

Tepper, Mark A. & James L. Roberts. (1984). Evidence for Only Oneβ-Luteinizing Hormone and Noβ-Chorionic Gonadotropin Gene in the Rat*. Endocrinology. 115(1). 385–391. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact